HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An immunological investigation of hemophilia B with a tentative classification of the disease into five variants.

Abstract
23 patients with hemophilia B have been investigated by means of several immunological methods. 16 patients (69.9%) had no detectable factor XI antigen. Five had a normal factor IX antigen and the electrophoretic mobility of this abnormal factor IX was similar to that of its normal counterpart. One of these five patients had hemophilia Bm, since ox brain thromboplastin clotting time was severely prolonged. The remaining two patients had reduced or decreased factor IX antigen. Several patients showed a slight protongation of ox brain thromboplastin time due to an associated slight factor VII deficiency. On the basis of these results, a tentative classification of hemophilia B into five variants is proposed, namely: hemctor IX antigen; hemophilia Bra, or with reduced factor IX antigen; hemophilia Bm, or with normal factor IX antigen and severely prolonged ox brain thromboplastin; hemophilia B patients is feasible only by means of a battery of tests, namely:factor IX activity assay, factor IX antigen determination, ox brain thromboplastin clotting time, factor VII activity assay.
AuthorsA Girolami, A Sticchi, A Burul, R D Zanon
JournalVox sanguinis (Vox Sang) Vol. 32 Issue 4 Pg. 230-8 ( 1977) ISSN: 0042-9007 [Print] England
PMID857424 (Publication Type: Journal Article)
Chemical References
  • Isoantigens
  • Factor VII
  • Factor IX
  • Factor XI
Topics
  • Factor IX (analysis)
  • Factor VII (analysis)
  • Factor XI (analysis)
  • Genetic Variation
  • Hemophilia B (classification, immunology)
  • Humans
  • Isoantigens (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: